Sermorelin
Sermorelin (GRF 1-29) is a synthetic 29-amino acid GHRH receptor agonist, investigated in research for pulsatile growth hormone secretion stimulation, GH axis regulation, and somatotroph cell signaling.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Sermorelin (GRF 1–29 NH₂) is a synthetic 29-amino acid peptide corresponding to the first 29 residues of endogenous growth hormone-releasing hormone (GHRH). In preclinical laboratory research, Sermorelin is extensively investigated as a GHRH receptor (GHRH-R) agonist that stimulates somatotroph cells of the anterior pituitary to release growth hormone (GH) through a cAMP-dependent signaling pathway. The peptide retains full biological activity of the native 44-amino acid GHRH, as residues 1–29 constitute the minimal bioactive sequence required for receptor binding and activation. Sermorelin serves as a fundamental research tool in neuroendocrinology, GH axis physiology, and pulsatile hormone secretion studies.
- Peptide
- Sermorelin (GRF 1–29 NH₂)
- Strength
- 5 mg
- Package
- 5mg
- Purity
- 99.27%
- Form
- vial
